Effects of a Dipeptidyl Peptidase 4 Inhibitor Sitagliptin on Glycemic Control and Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus (GLORIA Trial)

Aim: The morbidity of cardiovascular disease in patients with type 2 diabetes mellitus (DM) deteriorates in combination with dyslipidemia. The accumulation of remnant lipoproteins in patients with fasting and postprandial hypertriglyceridemia is highly atherogenic. The current study investigated whe...

Descripción completa

Detalles Bibliográficos
Autores principales: Masuda, Daisaku, Kobayashi, Takuya, Sairyou, Masami, Hanada, Hiroyuki, Ohama, Tohru, Koseki, Masahiro, Nishida, Makoto, Maeda, Norikazu, Kihara, Shinji, Minami, Tatsuya, Yanagi, Koji, Sakata, Yasushi, Yamashita, Shizuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005231/
https://www.ncbi.nlm.nih.gov/pubmed/29199201
http://dx.doi.org/10.5551/jat.41343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005231/
https://www.ncbi.nlm.nih.gov/pubmed/29199201
http://dx.doi.org/10.5551/jat.41343

Ejemplares similares